| Ticker Details |
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.
|
| IPO Date: |
June 1, 2012 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$179.54M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.24 | 4.41%
|
| Avg Daily Range (30 D): |
$0.49 | 3.01%
|
| Avg Daily Range (90 D): |
$0.51 | 3.00%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.29M |
| Avg Daily Volume (30 D): |
.35M |
| Avg Daily Volume (90 D): |
.51M |
| Trade Size |
| Avg Trade Size (Sh.): |
233 |
| Avg Trade Size (Sh.) (30 D): |
73 |
| Avg Trade Size (Sh.) (90 D): |
83 |
| Institutional Trades |
| Total Institutional Trades: |
308 |
| Avg Institutional Trade: |
$1.59M |
| Avg Institutional Trade (30 D): |
$.65M |
| Avg Institutional Trade (90 D): |
$1.64M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.04M |
| Avg Closing Trade (30 D): |
$.65M |
| Avg Closing Trade (90 D): |
$1.3M |
| Avg Closing Volume: |
42.92K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-3.59
|
$-3.86
|
$-2.84
|
|
Diluted EPS
|
$-3.59
|
$-3.86
|
$-2.84
|
|
Revenue
|
$3.29M
|
$2M
|
$2.43M
|
|
Gross Profit
|
$1.92M
|
$-1.27M
|
$1.49M
|
|
Net Income / Loss
|
$-32.01M
|
$-28.27M
|
$-16.83M
|
|
Operating Income / Loss
|
$-33.07M
|
$-28.3M
|
$-16.05M
|
|
Cost of Revenue
|
$1.37M
|
$3.27M
|
$.94M
|
|
Net Cash Flow
|
$65.11M
|
$-6.38M
|
$32.94M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Feb 05, 2025
|
1:100
|
|
Jun 10, 2024
|
1:32
|
|
May 10, 2023
|
4:25
|
|
May 17, 2022
|
1:32
|
|
Nov 01, 2019
|
1:10
|
|
Nov 28, 2018
|
1:10
|
|
Mar 17, 2017
|
1:10
|
|
May 01, 2013
|
1:20
|
|
|
|
